Comparative Study on the Efficacy and Safety of Different Left Atrial Appendage Occluders in One-Stop Atrial Fibrillation Procedures - Report - MDSpire

Comparative Study on the Efficacy and Safety of Different Left Atrial Appendage Occluders in One-Stop Atrial Fibrillation Procedures

  • By

  • Ren, Haoqiang

  • Lai, Hengli

  • May 8, 2026

  • 0 min

Share

Clinical Report: Efficacy and Safety of Left Atrial Appendage Occluders

Overview

This study evaluates the sealing efficacy and safety of three left atrial appendage (LAA) occluders in patients undergoing combined catheter ablation and LAA occlusion for atrial fibrillation. The findings indicate comparable effectiveness among the devices, with specific risk factors identified for peri-device leaks.

Background

Atrial fibrillation (AF) is a prevalent cardiac arrhythmia associated with a significant risk of stroke. Left atrial appendage occlusion (LAAO) is a critical intervention for stroke prevention in AF patients, particularly those who cannot tolerate long-term anticoagulation. Understanding the efficacy and safety of different LAA occluders is essential for optimizing patient outcomes in this high-risk population.

Data Highlights

DevicePeri-Device Leak Rate
WATCHMAN8.2% (9/110)
LAmbre6.9% (5/72)
LACBES4.1% (2/49)

Key Findings

  • Peri-device leak (PDL) rates were 8.2% for WATCHMAN, 6.9% for LAmbre, and 4.1% for LACBES.
  • No statistically significant differences in PDL rates among the three devices (P > 0.05).
  • A higher CHA₂DS₂-VASc score was identified as an independent risk factor for PDL.
  • Older age was found to be a protective factor against PDL.
  • No significant differences in device-related thrombus (DRT) or stroke incidence were observed during follow-up.
  • The study suggests the need for larger trials to confirm long-term safety outcomes.

Clinical Implications

Clinicians should consider the comparable efficacy of the WATCHMAN, LAmbre, and LACBES occluders when selecting devices for LAAO in AF patients. Attention should be given to patients with higher CHA₂DS₂-VASc scores and younger age, as they may require closer monitoring for peri-device leaks.

Conclusion

The study concludes that the three evaluated LAA occluders demonstrate similar effectiveness in achieving LAA closure during a one-stop AF procedure. Further research is warranted to validate these findings and assess long-term safety.

Related Resources & Content

  1. Clinical Research in Cardiology, 2024 -- Efficacy and Safety of LAA Occlusion in Atrial Fibrillation Patients with Previous Stroke
  2. Frontiers in Cardiovascular Medicine, 2026 -- The impact of preoperative left atrial appendage thrombus on surgical outcomes in atrial fibrillation patients undergoing epicardial left atrial appendage closure
  3. Frontiers in Cardiovascular Medicine, 2026 -- Correction: A comparable efficacy and safety between intracardiac echocardiography and transesophageal echocardiography for percutaneous left atrial appendage occlusion
  4. Clinical Research in Cardiology, 2021 -- Influence of Atrial Fibrillation Types on Outcomes Following Left Atrial Appendage Closure: Insights from the LAARGE Registry Study
  5. 2023 Guideline for Diagnosis and Management of Atrial Fibrillation: Key Perspectives - American College of Cardiology
  6. Left Atrial Appendage Closure after Ablation for Atrial Fibrillation - PubMed
  7. State-of-the-Art of Transcatheter Left Atrial Appendage Occlusion | MDPI
  8. 2023 Guideline for Diagnosis and Management of Atrial Fibrillation: Key Perspectives - American College of Cardiology
  9. Left Atrial Appendage Closure after Ablation for Atrial Fibrillation - PubMed
  10. State-of-the-Art of Transcatheter Left Atrial Appendage Occlusion | MDPI

Original Source(s)

Related Content